Arcellx
  • Our Company
    • About Us
    • Leadership
    • Board of Directors
    • Investors
  • Our Technology
    • ARC-sparX Platform
    • Scientific Publications
  • Our Pipeline
    • Pipeline Overview
    • Therapeutic Areas
      • Oncology
      • Autoimmune
    • Clinical Trials
  • News & Presentations
    • Press Releases
    • Scientific Publications
  • Careers
    • Our Values
    • Job Opportunities
  • Contact Us

News & Presentations

6.22.2020

Arcellx Presents Preclinical Data for ARC-sparX Platform Technology in Targeting CD123-Positive AML Tumors

Read More

6.02.2020

Arcellx to Present at Jefferies Virtual Healthcare Conference

Read More

5.19.2020

Arcellx to Present at the UBS Virtual Global Healthcare Conference

Read More

5.13.2020

Arcellx to Present Preclinical Data of its Novel ARC-sparX Platform Technology in Targeting HER2+ Solid Tumors at the 2020 American Society of Clinical Oncology Virtual Annual Meeting

Read More

4.29.2020

Arcellx to Present Preclinical Efficacy Data of the ARC-sparX Platform Technology at the 2020 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Read More
« Previous123Next » View All
  • Press Releases
  • Scientific Publications
Arcellx

Arcellx, Inc.

25 West Watkins Mill Road, Suite A
Gaithersburg, MD 20878
info@arcellx.com
  • Privacy Policy
  • Terms & Conditions
  • Site Map

© 2021 Arcellx. All Rights Reserved.